PALATIN TECHNOLOGIES INC (PTN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · PTN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -72.5% |
| Our one-year growth estimate | diamond | -41.6% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 30.9 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and has erratic recent earnings surprises. A fundamental tilt, not a price call.
Model as of 2026-09-04 · Compared with 399 industry peers
PTN — legal / regulatory event — Notice
Dated 2026-05-18
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 18, 2026, Palatin Technologies, Inc. (the “Company”), acting pursuant to authorization from its Board of Directors, provided notice to the NYSE American LLC (the “NYSE”) that it intends to voluntarily withdraw the listing of its common stock, par value $0.01 per share (the “common stock”), from the NYSE and transfer the listing of its common stock to the Nasdaq Capital Market (the “Nasd…
Why it matters: The transfer could impact trading volume and investor perception of the stock.
Worry ifThe transfer is completed and the stock begins trading on Nasdaq without delays.
Less concerning ifThe transfer is delayed or canceled, keeping the stock on NYSE.
Why it matters: Completing this raise would provide essential funds to support operations and growth.
Supportive ifThe company raised $15.8 million. This is a successful capital raise.
Worry ifNo announcement or delays in the capital raise process.
Why it matters: A drop in revenue means the company is not doing well. This could make investors worried.
Worry ifQ2 revenue reported below $116K.
Less concerning ifQ2 revenue reported above $116K.
Why it matters: Stabilizing revenue shows progress in making more money after a big drop.
Supportive ifQ3 revenue was over $8M. This shows recovery from $116K in Q2.
Worry ifQ3 revenue was below $8M. This shows ongoing ups and downs in revenue.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$351 on $10,000 · ±3.5% | How much price usually moves either way. |
| Bad day | $1,002 loss on $10,000 · 10.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $7,371 loss on $10,000 · 73.7% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: A successful capital raise will help Palatin grow. It is important for funding projects.
Supportive ifPalatin says it has finished raising $15.8 million.
Worry ifPalatin does not finish the capital raise or delays the news.
Why it matters: Moving to Nasdaq may help more people see the stock. This could bring in more investors and improve trading.
Supportive ifSuccessful transition to Nasdaq with no trading disruptions on May 29, 2026.
Worry ifAny delays or issues in the transition process to Nasdaq.
Why it matters: A successful transfer could improve trading and attract more investors.
Supportive ifAn official announcement confirms the transfer to Nasdaq is done.
Worry ifNo progress reported on the transfer by the next earnings date.
Why it matters: Moving to Nasdaq could help PTN get more attention. It may also increase trading activity.
Supportive ifPalatin begins trading on Nasdaq as scheduled on May 29, 2026.
Worry ifThe listing transition is delayed or canceled.
Why it matters: Submitting the IND is an important step for Palatin's obesity treatment. It shows they are making progress.
Supportive ifPalatin will submit the IND for the MC4R peptide program in Q4 2026.
Worry ifThe IND submission is delayed beyond Q4 2026.
Why it matters: Better cash flow is important for Palatin's finances. It shows they are managing money well.
Supportive ifCash from operations will be positive in Q4 2026.
Worry ifCash from operations will still be negative in Q4 2026.